ObjectivesMetal-on-metal hip resurfacing (MOMHR) is available as an alternative
option for younger, more active patients. There are failure modes
that are unique to MOMHR, which include loosening of the femoral
head and fractures of the femoral neck. Previous studies have speculated
that changes in the vascularity of the femoral head may contribute
to these failure modes. This study compares the survivorship between
the standard posterior approach (SPA) and modified posterior approach
(MPA) in MOMHR. MethodsA retrospective clinical outcomes study was performed examining
351 hips (279 male, 72 female) replaced with Birmingham Hip Resurfacing
(BHR, Smith and Nephew, Memphis, Tennessee) in 313 patients with
a pre-operative diagnosis of osteoarthritis. The mean follow-up
period for the SPA group was 2.8 years (0.1 to 6.1) and for the
MPA, 2.2 years (0.03 to 5.2); this difference in follow-up period
was statistically significant (p < 0.01). Survival analysis was
completed using the Kaplan–Meier method. ResultsAt four years, the Kaplan–Meier survival curve for the SPA was
97.2% and 99.4% for the MPA; this was statistically significant
(log-rank; p = 0.036). There were eight failures in the SPA and
two in the MPA. There was a 3.5% incidence of femoral head collapse
or loosening in the SPA and 0.4% in the MPA, which represented a
significant difference (p = 0.041). There was a 1.7% incidence of
fractures of the femoral neck in the SPA and none in the MPA (p
= 0.108). ConclusionThis study found a significant difference in survivorship at
four years between the SPA and the MPA (p = 0.036). The clinical
outcomes of this study suggest that preserving the vascularity of
the femoral neck by using the MPA results in fewer vascular-related
failures in MOMHRs.Cite this article: Bone Joint Res 2014;3:150–4
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.